Click to watch the live stream and join the conversation. #PhRMA16

0 SHARES

0

0

0

36

0 SHARES

0

0

0

36

Working for Patients

America’s biopharmaceutical companies are working to discover and develop new medicines for patients. These efforts are paying off with remarkable gains in the fight against disease.

America’s biopharmaceutical companies are working to discover and develop new medicines for patients. These efforts are paying off with remarkable gains in the fight against disease.

  • I'm Not Average

    Read the inspirational stories of patients who have overcome deadly diagnoses and are now living active, healthy lives.

    Read more
  • Infographic: Working For Patients

    America's biopharmaceutical companies create medicines that provide hope that a cure can be found, treatment will be effective and lives can be lived to their fullest.

    Read more
  • Join “I’m Not Average,” a community for patients and supporters

    Join the online “I’m Not Average” community on Facebook and Twitter, and show your support for those that embody strength during hardship.

    Read more
  • PPA: More than just prescription assistance

    Since its launch in 2005, the Partnership for Prescription Assistance – or PPA – has helped connect nearly 9.5 million people with public and private patient assistance programs.

    Read more
  • Long-term survival rates double for melanoma patients getting immunotherapy

    More than a third of advanced-melanoma patients who received one of the new immunotherapy drugs in an early trial were alive five years after starting treatment -- double the survival rate typical of the disease, according to a new study.

    Read more

The fight against some of the world's most troubling diseases is changing, with innovative medicines enriching outcomes. In the U.S., the death rate from HIV/AIDS has dropped by nearly 85 percent since its peak in the mid-1990s, transforming an acute, fatal illness to a chronic condition. It is estimated that, as a result of innovative medicines, over 862,000 premature deaths have been avoided and nearly 27 million life-years have been gained.1 Earlier diagnoses and new treatments have helped boost the 5-year cancer survival rate to 68 percent.2  And while hepatitis C was incurable in half of patients just a decade ago, new treatments have cure rates upwards of 90 percent and have far fewer side effects.

Unfortunately, major health challenges remain unsolved. But with more than 7,000 medicines in development globally, and by continuing to work with patients, we get closer to new treatments and more cures, every day.


I'm Not Average: Videos


I'm Not Average shares inspirational stories from patients who have survived rare and deadly diseases. Learn about the powerful impact that innovations in medicines have had on their lives.

  • For Cancer Survivors Like Matt, Today is a New Opportunity

    Learn more about Matt, as he highlights how participation in a clinical trial and innovation from America’s biopharmaceutical research companies has kept him alive.

    Watch the Video
  • We're Fighting Back

    Every patient has a story. Share yours with I'm Not Average.

    Watch the Video
  • I’m Not Average: Doreen’s Struggle with Cholesterol

    Doreen is a 60 year-old heart attack survivor who is committed to living a healthy life and staying alive for her children and grandchildren.

    Watch the Video
  • Loretta is Still Living Well 12 Years After Her Diagnosis

    Loretta was diagnosed with Stage 4 lung cancer in 2003. At first, she thought it was a death sentence - but in time she resolved, "I will live with this and I will live well for the rest of my life."

    Watch the Video
  • Jack Whelan is Surviving Blood Cancer Thanks to Science & Innovation

    Diagnosed with Waldenström macroglobulinemia, a rare, incurable form of blood cancer, Jack was told he had just five years to live. Today, Jack continues to defy expectations thanks to scientific research and innovation.

    Watch the Video
  • Marina is Living Well in Spite of Stomach Cancer

    When Marina was diagnosed with gastrointestinal stromal tumor (GIST), the doctors told her she had weeks to live. Today, she is living well in spite of GIST.

    Watch the Video
  • Matt Ellefson May Have Cancer, But Cancer Doesn’t Have Him

    When Matt was diagnosed with advanced non-small lung cancer, his prognosis was a 5 year survival rate of less than 5 percent. Because of the progress made in cancer research, he now leading an active and happy life.

    Watch the Video
  • Jamie is Conquering the Challenges of Living with Chronic Myelogenous Leukemia

    Jamie was diagnosed in 2001 with chronic myelogenous leukemia, and thought she would not be able to watch her son grow up. Today, she is living a happy, normal life.

    Watch the Video
  • CJ is Living with Cancer Despite the Odds

    CJ is a cancer survivor who wants to help others who have been diagnosed with cancer.

    Watch the Video

connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


  • +68K

    Followers

  • +40K

    Followers

  • 368

    Followers

  • 1408

    Subscribers